Brief: Akari Therapeutics To Present Oral Abstract At SITC’S 40th Annual Meeting
03/10/2025 15:05
Oct 3 (Reuters) - Akari Therapeutics PLC AKTX.O: AKARI THERAPEUTICS ANNOUNCES ABSTRACT ACCEPTED FOR ORAL PRESENTATION AT THE 40TH ANNUAL SOCIETY FOR IMMUNOTHERAPY OF CANCER (SITC) MEETING Source text: ID:nGNX8PZ17j Further company coverage: AKTX.O ((Reuters.Briefs@thomsonreuters.com;))